Welcome to Genetics Digest.

Our goal is to provide credible, accurate information about the latest advancements in DNA analysis and genome technology. We have news alerts for scientists and DNA enthusiasts and unbiased product reviews for consumers looking to purchase anything related to the field of genetics, so that scientists and consumers can make educated decisions when studying DNA.

We are a team of writers and scientists who are passionate about all things DNA—from double helixes to chromosomes to mitochondrions, we love it all.

With new trends emerging every day (like DNA ancestry tests) as genetic information becomes more accessible to common consumers, we feel it’s necessary that the complex science involved becomes more accessible to common consumers as well.

We’ve found that many magazines about Genetics are a little TOO sciencey, so that the consumers unfamiliar with the field have no idea what they’re reading. On the other hand, the non-science magazines are written by non-scientists, and they often butcher their information a little bit…

Genetics Digest bridges the gap, where scientists and common consumers can come together to get the same information and understand it. So, while we provide useful information to scientists, we make sure to keep our lingo as readable to the common man as possible without sacrificing any accuracy in the information.


Erin Wildermuth

Erin Wildermuth is a science writer based in Miami. She is passionate about using technology to improve human health.





Nikki Collins

Nikki Collins is a freelance writer and scientist. Her scientific experience ranges from academic research at IU School of Medicine to the public health arena working in institutions such as Centers for Disease Control and Prevention (CDC). When not in a lab or at a computer, she enjoys almost anything outdoors, dance, and reading.


Helen Santoro

Helen Santoro is a Boston-based science writer who has been working in the field of science for over six years. Before moving to the bustling city, Helen attended Hamilton College where he received Bachelor of Arts in Neuroscience. She then worked as a res archer at Boston Children’s Hospital where she helped uncover the mechanisms behind acute and chronic pain conditions with the long-term goal of improving patient care. Her writing has spanned from genome engineering to biochemistry to gender issues in the STEMM field.

Dr Okoye

Dr Obianuju Helen Okoye

Dr. Obianuju Helen Okoye is an American Public Health Physician/Health Care Executive/Researcher/Entrepreneur with a Medical Degree (MD), an MBA in Healthcare Management, and a Masters in Epidemiology/Public Health) with vast experience in clinical medicine, public health, mental health, telemedicine, Market Access, Health Economics and Outcomes Research, coupled with an exceptional background in Health Care Administration and Clinical expertise. She has been featured on NBC News, Yahoo News, The Huffington Post, Tonic by VICE, She Knows, Massage Magazine, Carol Roth, among others.She is a contributing writer to Entrepreneur magazine and the Huffington Post, and has been a scientific writer for the renowned websites The Paleo Diet and AusMed. Her background includes being a National Institutes of Health (NIH) Clinical and Research Fellow, and State of Michigan HIV/AIDS Epidemiologist. She has a plethora of clinical research experience and has presented at US and International Medical Conferences. Dr. Okoye has authored some publications, and is considered an expert on the Affordable Care Act. Dr. Okoye’s interests include disease prevention, empowering under-served communities globally, bridging access (to) and streamlining the delivery of healthcare services.

Dr Okoye started the blog community Important Goals, to empower people to live their best lives. She is the CEO/President of SK Global LLC, with a focus on taking healthcare and business projects globally, from inception through successful delivery of value propositions to stakeholders. She is open to clinical, healthcare and international business opportunities and strategic innovations.


Chelsea Weidman

Chelsea is a biochemist and freelance science writer/editor interested in genetics, gene editing technologies, stem cells, and novel medications. She has written for Massive and Harvard University’s Science in the News.


Her research has focused on a range of topics such as molecular imaging agents, reversible covalent chemistries, and novel antibiotic strategies. She received her Bachelor of Science degree in Biochemistry and her Master of Science degree in Chemical Biology.